Neurexins are highly polymorphic cell surface proteins expressed in central and peripheral neurons. There are at least three neurexin genes in mammals, each of which contains two independent promoters that initiate transcripts for (Y-and p-neurexins (Ushkaryov et al., 1992 (Y-and p-neurexins (Ushkaryov et al., , 1994 Ushkaryov and Siidhof, 1993) . The primary transcripts of neurexins are extensively alternatively spliced, resulting in hundreds to thousands of isoforms (Ullrich et al., 1995) . The six principal neurexins (neurexins la-3a and l/3--3@ and their alternatively spliced forms are expressed in a differential manner in brain, with each type of neuron coexpressing different subsets of neurexins.
The structure of the neurexins resembles that of a cell surface receptor. Three putative extracellular ligands for neurexins have been identified. (1) Neurexin la binds with high affinity to cY-latrotoxin, a potent excitatory neurotoxin from black widow spider venom (Ushkaryov et al., 1992; Davletov et al., 1995) . (2) A subset of p-neurexins lacking an insert in splice site #4 binds to neuroligins, a recently discovered family of neuronal cell surface receptors (Ichtchenko et al., 1995) . Similar to neurexins, neuroligins are encoded by at least three genes and are subject to alternative splicing (Ichtchenko et al., 1996) . (3) A 29 kDa protein called neurexophilin copurifies with neurexin lcu and structurally resembles a neuropeptide, suggesting that it may represent a soluble ligand for a-neurexins (A. Petrenko and T. Siidhof, unpublished observations). Recei ved Dec. 12, 1995; revised Jan. 17, 1996; accepted Jan. 19, 1996 The structures of neurexins, their highly polymorphic nature, and the splice site-specific interaction of fi-neurexins with neuroligins suggest a function as cell adhesion/signaling molecules and a possible role in mediating intercellular recognition events. Because a-latrotoxin acts at synapses and at least some neurexins localize close to synapses, it has been speculated that neurexins may be involved in the formation of synaptic junctions. Such a role is supported by the interaction of the intracellular domains of neurexins with synaptotagmin I, a synaptic vesicle Ca2+-sensor (Petrenko et al., 1991; Hata et al., 1994) . However, although this interaction is stoichiometric and sequence-specific, it could not be detected by a yeast two-hybrid assay (Hata et al., 1995) , and synaptotagmin I is not required for a-latrotoxin action (Geppert et al., 1994) . Therefore, the functional importance of the interaction of neurexins with synaptotagmin I is unclear.
The molecular components of several types of intercellular junctions have been characterized in detail in recent years. Pioneered by the description of the dig-A gene in Drosophila (Woods and Bryant, 1991) , a class of molecules was discovered with members at different types of intercellular junctions. The dlg-A gene encodes a component of septate junctions that are disrupted by mutations in dig-A (Woods and Bryant, 1991) . The gene is evolutionarily conserved, with at least two homologs in humans (Lue et al., 1994; Mazoyer et al., 1995) . In addition, dig-A is homologous to the tight junction proteins ZO-1 and 20-2 (Itoh et al., 1993; Tsukita et al., 1993; Willott et al., 1993; Jesaitis and Goodenough, 1994) and the synaptic proteins PSD95/SAP90 and SAP97 (Cho et al., 1992; Kistner et al., 1993; Miiller et al., 1995) . All of these proteins exhibit similar domain structures: a set of N-terminal repeats called DHR domains (for "disks-large homology region"), a middle SH3 domain, and a C-terminal region comprised of a guanylate kinase domain that is probably not catalytically active. An additional member of this protein family is ~55, a plasma membrane protein of erythrocytes that is involved in attaching the cytoskeleton to the membrane and may be im-portant for determining erythrocyte shape (Ruff et al., 1991; Alloisio et al., 1993; Marfiata et al., 1994) . The function of p.55 suggests that members of this protein family may be involved in establishing specialized membrane structures via interactions with the membrane cytoskeleton and integral membrane proteins, resulting either in intercellular junctions between cells or a particular membrane shape in a cell.
We have now used yeast two-hybrid (Y2 H) screens to identify molecules that bind to the intracellular C terminus of neurexins. A single interacting protein was discovered that is composed of an unusual combination of domains. Its N-terminal region is highly homologous to Ca'+, calmodulin-dependent protein kinases (CaM kinases) that are ubiquitous Cazf-dependent signaling proteins. Its C terminus is very similar to the dlg-homologs DLG2, ~5.5, PSD95iSAP90, and 20-l/20-2. This is the first time that a fusion between a CaM kinase and a junction-like protein has been observed, suggesting a signaling molecule that may be involved in cell-cell communication events. (Schiestl and Gietz, 1989) . Transformants were selected on plates lacking histidine, uracil, tryptophan, and leucine. Positive clones were picked after 4-6 d at 3O"C, and the P-galactosidase activity of the clones was assayed by the filter method. Extrachromosomal DNA was isolated from clones that grew in the absence of histidine and that were P-galactosidase positive using the glass bead method (Ward et al., 1990) . Prey plasmids were rescued in Escherichia coli HBlOl cells by electroporation and selection on M9 plates containing 50 mg/l proline and 0.1 gmil ampicillin.
MATERIALS AND METHODS
For quantitation of P-galactosidase activity, yeast strains transfected with bait and prey vectors were grown in supplemented minimal medium lacking uracil, tryptophan, and leucine in a shaking incubator at 30°C for 48 hr. /3-Galactosidase assays were performed on yeast extracts with protein concentrations of 20-40 mg/l per assay as described previously (Rose et al., 1990) . cDNA cloning, DNA sequencing, construction of expression vectors, and COS cell expression. To determine the complete structure of CASK, the insert of pPeyCASK600 was used to screen a rat brain cDNA library in XZAPII (Stratagene, La Jolla, CA) by standard cDNA cloning methods (Sambrook et al., 1989) . Thirty positive clones were isolated from -3 million plaques. The six largest clones were selected for sequence analysis (pCASH2A, 3A, (Jones and Matus, 1974; Brose et al., 1995) . Briefly, rat brain homogenates were centrifuged at 800 X g to remove nuclei and aggregates; the supernatant was centrifuged at 9000 X g to obtain a low-speed supernatant and a crude synaptosomal pellet that was lysed hypoosmotitally and centrifuged at 25,000 X g to prepare synaptosomal membranes. These were then subfractionated on a sucrose gradient into the different membrane fractions as described previously (Jones and Matus, 1974 
RESULTS

Yeast two-hybrid screens for neurexin interacting proteins
One million, 4 million, and 6 million yeast transformants with a rat brain cDNA library were screened for proteins interacting with neurexins 1, 2, and 3, respectively. Only a single positive clone was identified from the neurexin 2 screen and 3 positive clones from the neurexin 3 screen. Restriction mapping and sequencing revealed that all four clones represented isolates of a single cDNA, pPreyCask600. Retransformations of yeast with the bait and prey plasmids singly or in combination demonstrated that P-galactosidase activation occurred only when pPreyCask600 was cotransformed with one of the three neurexin bait constructs but not with unrelated bait constructs, suggesting that the interaction observed was specific (data not shown). Because of its homologies (see below), we named the protein encoded by the prey vector CASK. Hata et al. l 
Structure of CASK
Using the cDNA insert of pPreyCask600, we isolated full-length clones from a rat brain cDNA library. Their translated amino acid sequence is assembled in Figure 1 . Multiple overlapping cDNAs were characterized that contained identical sequences except for a short region in which two sequence variants were observed. Of four clones, three were identical but one clone contained a distinct in-frame sequence that was homologous to that present in the other clones (bold in Fig. 1 ). The homology between the two sequences suggests that its presence does not represent a cloning artifact but is attributable to differential splicing similar to that observed in dynamins and other neural proteins where distinct but homologous sequences are also differentially inserted at positions of alternative splicing (Sontag et al., 1994) . Databank searches revealed that the protein encoded by the CASK cDNAs is composed of a series of defined domains that were not previously observed in this combination (Figs. 2&? ). The N-terminal third of CASK is highly homologous to Ca'+, calmodulin-dependent protein kinases (CaM kinases). The strongest homology is found with Ca'+, calmodulin-dependent protein kinase II (CaMK II; 45.0% identity over 322 amino acids). This homology includes the autoinhibitory and calmodulin binding domain of CaMK II which extends from residues 281-310 (Hanson and Schulman, 1992; Haribabu et al., 1995) . Of the 18 residues of the CaM binding sequence of CaMK II (residues 293-310), 11 are identically present in CASK (Fig. 24) . The threonine of the autophosphorylation site of CaMK II (Thr'a") in the autoinhibitory domain is also conserved in CASK (Thr'"'). However, immediately preceding the threonine, CASK contains the sequence 'X7HLPET'"' as opposed to 1x2HRQET'8h in CaMK II. The substitution of the arginine in CaMK II for leucine in this sequence in CASK suggests that this is not a good CaMK substrate and that Thr'"' m CASK may not be an autophosphorylation site.
Immediately after the calmodulin binding domain, the CASK sequence diverges from that of other CaM kinases. After a short linker sequence that is homologous to a human d&-A homolog (DLG2; Mazoyer et al., 1995) the C-terminal half of CASK assumes a high degree of similarity to a set of proteins that includes the erythrocyte plasma membrane protein ~55, the synaptic junction proteins PSD95lSAP90 and SAP97, the Drosophila septate junction protein dig-A and its human homologs, and the tight junction proteins ZO-1 and 20-2 ( Fig. 2 ; Ruff et al., 1991; Cho et al., 1992; Itoh et al., 1993; Kistner et al., 1993; Tsukita et al., 1993; Willott et al., 1993; Jesaitis and Goodenough, 1994; Miiller et al., 1995) . All of these proteins are characterized by the presence of three separate domains: N-terminal DHR repeats that are present in a single copy in CASK, DLG2, and ~55; a middle SH3 domain; and a C-terminal guanylate kinase-like sequence that lacks several residues thought to be essential for enzyme activity. The unusual combination of CaM kinase and dlg-like domains observed in CASK is not a cDNA cloning artifact because the same combination of domains was observed in multiple independent cDNA clones with different sequence boundaries. Thus, CASK is composed of a mosaic of domains that include signaling modules (CaM kinase and SH3 domains) and putative intercellular junction and cytoskeletal attachment domains (the d&-A homologous set of domains).
Properties and tissue distribution of CASK
To study the tissue distribution of CASK, we performed RNA and protein blotting experiments. For this purpose, antibodies were raised to recombinant GST-CASK fusion proteins. The specificity of the antibodies was confirmed in immunoblots comparing COS cells transfected with control DNA and with the CASK expression vector (see below). Both RNA blots and immunoblots revealed that CASK is primarily expressed in brain (Fig. 3) . However, in contrast to the brain-specific neurexins, lower levels of CASK are ubiquitously present in all cells and tissues tested. Quantitative immunoblots using '251-1abeled secondary antibodies demonstrated that brain expresses approximately fourfold more CASK than kidney, the highest peripheral tissue, whereas other tissues contain lower levels (5-20% of brain levels; data not shown).
To determine if CASK is a soluble protein, tissues were separated into membranes and cytosol. CASK was associated with the membrane pellet and could be partially solubilized in detergents but not with high salt (data not shown). This is consistent with the notion that CASK may be a peripheral membrane protein. , 19%) . The sequences of the C-terminal domams of CASK arc aligned with those of the human dlg-A homolog DLG2, the erythrocyte protein ,055, the synaptic proteins PSD95/SAP90 and SAP97 (~95 and p97), and the tight junction proteins ZOI and 202 (sequcnccs ate from Ruff et al., 1991; Cho ct al., 1992; Jcsaitis and Goodenough, 1994; Mazoyer et al., 1995; Muller et al., 199.5) Figure 3 . Tissue distribution of CASK expression. Homogenates from the indicated rat tissues were analvzed bv immunoblottine usine affinitypurified CASK antibodies. Immunoreactive bands were reicted Lith "'Ilabeled secondary antibodies and exposed to film. Numbers on the left indicate positions of molecular weight standards. PhosphorImager quantitation suggests that the levels of CASK in brain are -4 times higher than in kidney, and 5-20 times higher than in other non-neural tissues.
was highly enriched in the so-called synaptic plasma membrane fraction whereas the myelin and mitochondrial fractions contained virtually no CASK in spite of equal protein loads (Fig. 4) . The synaptic plasma membranes represent a fraction that contains synaptic junctions but also other parts of neuronal and glial plasma membranes, allowing no definitive conclusion about the part of the plasma membrane CASK may be associated with (Jones and Matus, 1974) . Because the N-terminal domain of CASK is highly homologous to CaM kinases, we tested whether it possesses kinase activity or binds calmodulin. No kinase activity could be demonstrated with recombinant protein, possibly because an additional regulatory step similar to CaMKI and IV is required (Haribabu et al., 1995; Tokumitsu et al., 1995) . In addition, no autophosphorylation was observed with CASK kinase domains expressed in bacteria, COS cells, or baculovirus (data not shown). However, recombinant fragments of CASK containing its putative calmodulin binding site bound calmodulin efficiently in a Ca2+-dependent manner, supporting the notion that calmodulin regulates CASK activity (data not shown).
Specificity of the interaction of CASK with the cytoplasmic domains of neurexins Deletion mutants of CASK and of neurexins were tested for interactions in the Y2 H assay to determine their specificity. Deletions in CASK that were smaller than the originally isolated Y2 H prey clone (containing residues 218-909) abolished the interaction whereas longer sequences of CASK were active (data not shown). This suggests that several domains in CASK may be required for the interaction with neurexins. By contrast, deletion analysis of the cytoplasmic domain from neurexin 1 revealed that deletions from the N terminus of the cytoplasmic domain of neurexin 1 weakened but did not abolish the interaction (Table 1) . Deletions from the C terminus, however, severely inhibited the interaction, with a deletion of only three amino acids being sufficient to abolish binding in the Y2 H assay.
To confirm the interaction of CASK with neurexins biochemically, full-length and deleted sequences from the cytoplasmic domain of neurexin 1 identical to those used in the Y2 H assays (Table 1) were isolated from' hype-osmotically lysed synaptosomes by centrifugation and subjected to sucrose gradient centrifugation, yielding fractions enriched in synaptic plasma membranes (Syn. Plasma Membrane), mitochondria, and myelin (Jones and Matus, 1974) . Equivalent amounts of the fractions were analyzed by SDS-PAGE and immunoblotting for CASK (A) and neuroligin (B; antibody used recognizes all three neuroligins) as plasma membrane markers, and for synaptophysin as a synaptic vesicle marker and complexins as cytosolic proteins (C). The smaller bands observed in the CASK immunoblots probably represent proteolytic products generated during membrane purification because such bands are never observed in fresh total brain samples (Fig. 3) . transfected with CASK, the resin was washed extensively, and bound proteins were analyzed by immunoblotting (Fig. 4) . As a control, an MBP-fusion protein with SNAP-25 was used.
CASK binding was only observed to MBP-fusion proteins containing neurexin sequences. It was independent of Ca2+. A 16 amino acid deletion from the N terminus of the cytoplasmic domain of neurexin 1 resulted in decreased binding; a deletion of 25 residues completely inhibited it. On the C-terminal side, all deletions abolished binding, even the removal of only three amino acids was sufficient to prevent the interaction (Fig. 4) . These results are similar to those obtained in the Y2 H assays with the same deletion mutants (Table 1 ) except that in the Y2 H assay the 25 residue N-terminal deletion still interacted whereas biochemically no binding was observed. Together these results suggest that CASK interacts with neurexins in a sequence-specific manner. However, this interaction was very sensitive to salt and no coimmunoprecipitation of neurexins with CASK could be observed under standard conditions (data not shown).
DISCUSSION
Neurexins are putative recognition molecules displayed on the neuronal cell surface (Ushkaryov et al., 1992 ). As such, they are thought to interact extracellularly with other cell surface proteins such as neuroligins (Ichtchenko et al., 1995 (Ichtchenko et al., , 1996 thereby mediating cell-cell interactions. By analogy with other cell-cell interaction molecules, neurexins might be expected to transduce extracellular binding events into intracellular signals. This could be achieved by binding of neurexins to signal transduction molecules, to proteins interacting with the cytoskeleton, or to junction proteins. In the current study we have identified such a protein molecule by the Y2 H assay. We found a novel protein called CASK that interacts with the intracellular domains of all neurexins. The structure of CASK suggests functions in signal transduction events involving Ca '+, in organizing plasma membrane domains such as intercellular junctions, and in mediating the attachment of the cytoskeleton to intrinsic membrane proteins. These findings are compatible with the notion that neurexins transduce extracellular recognition signals into intracellular responses at the plasma membrane.
Three lines of evidence support the hypothesis that CASK specifically interacts with neurexins (1) CASK was independently isolated in multiple screens using different neurexin tails. (2) The interaction of CASK with neurexins could be reproduced with recombinant proteins in vitro. (3) Binding of CASK to the neurexin tails was sequence dependent. Small deletions from either CASK or the neurexin tail domains abolished the interaction in both the Y2 H assay and in the in vitro binding assay. However, although CASK is firmly associated with membranes in a saltresistant manner, the interaction between CASK and neurexins is salt-labile and was disrupted by 0.5 M NaCl. Furthermore, the interaction could not be demonstrated by immunoprecipitations, suggesting that the interaction is weak. Together with the observation that CASK is present outside of brain where neurexins are absent, these data indicate that CASK is not primarily membrane associated via its interaction with neurexins but may also interact with other proteins.
CASK is composed of a mosaic of distinct domains that were described previously in a number of separate proteins. Its N-terminal third is comprised of a CaM kinase-like domain that The P-galactosidase activity of cell extracts from yeast harboring both plasmids was measured in triplicates and is shown as mean t SD in arbitrary units (Hata and Stidhof, 1995) . The bait vectors containing the neurexin tails encode the full-length cytoplasmic domains of neurexins 1, 2, and 3 (pBTMll(,Nela, 2a, and 3a, respectively), or parts of the cytoplasmic tail from neurexin I. pBTM116NelAl
and A2 contain deletions of 16 or 25 residues, respectively, from the N terminus of the cytoplasmic domain, and pBTMllhNelA3
and A4 contain deletions of IO and 3 amino acids, respectively, from the C terminus of the domain (Hata et al., 1993) .
binds calmodulin as a function of Ca'+. Although homologous to all CaM kinases described, it is most homologous to CaM KII, with which it shares almost 50% sequence identity (Bennett and Kennedy, 1987; Hanley et al., 1987; Lin et al., 1987; Hanson and Schulman, 1992) . C-Terminally to the CaM kinase module, CASK contains a set of domains that was previously identified in a family of intercellular junction proteins homologous, first in the Drosophila d&-A gene product. This family includes the synaptic junction proteins PSD95/SAP90 and SAP97, the tight junction proteins ZO-1 and 20-2, the erythrocyte membrane protein ~55, and the mammalian homologs of the Drosophila dlg-A gene hDLG and DLG2 (Woods and Bryant, 1991; Cho et al., 1992; Itoh et al., 1993; Kistner et al., 1993; Tsukita et al., 1993; Willott et al., 1993; Jesaitis and Goodenough, 1994; Lue et al., 1994; Mazoyer et al., 1995; Miiller et al., 1995) .
All of these proteins are peripheral membrane proteins that are composed of N-terminal DHR repeats, a single SH3 domain, and a noncatalytic guanylate kinase domain. Except for ~55, these proteins are localized to a variety of intercellular junctions where they may organize plasma membranes into junctional domains. By contrast, ~55 is uniformly distributed over the erythrocyte plasma membrane where it probably mediates the interaction of an intrinsic membrane protein, glycophorin C, with protein 4.1 and thereby contributes to determining the unusual shape of erythrocyte (Ruff et al., 1991; Alloisio et al., 1993; Marfiata et al., 1994) . The high degree of sequence similarity between the dlg-A like proteins, ~55, and CASK raises the possibility that CASK is also involved in organizing special domains of the plasma membrane by binding to intrinsic membrane proteins such as the neurexins and to protein 4.1 or its homologs ezrin, meosin, merlin, or radixin. This hypothesis is supported by the tight association of CASK with the synaptic plasma membrane.
The combination of domains found in CASK has not been observed previously in a single protein. Although many dlg-A homologs have been described, none of them is fused to a signal transduction module. Conversely, in spite of the presence of several CaM kinases in eukaryotic cells, these are not fused to a putative plasma membrane organizer as CASK is
